SuperDimension Inc. raised $24.8 million, according to the Globes news service.
The Plymouth, Minn.-based startup, which also has offices in Israel and Germany, is developing GPS-like technology designed to detect early stages of lung cancer. Dubbed electromagnetic navigation bronchoscopy, SuperDimension’s system allows doctors to probe the deepest regions of the lungs, guided by sensors and 3D mapping software.
CEO Dan Sullivan is a former top executive at Vascular Science and SciMed Life Systems. Boston Scientific Corp. (NYSE:BSX) acquired SciMed (now its cardiovascular business run out of Maple Grove, Minn.) for $850 million in 1995.
SuperDimension has raised more than $100 million from investors including pharmaceutical giant Pfizer, CIBC World Markets and OrbiMed Advisors.